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1. Introduction 
It has been shown [ 1 ] that vasopressin stimulates 
glycogenolysis in the rat liver at concentrations which 
can occur in vivo, especially during haemorrhagic 
shock. We report here that the glycogenolytic effect 
of vasopressin is due to the activation of glycogen 
phosphorylase, the rate limiting enzyme in glycogen 
degradation. The mechanism involved appears differ- 
ent from that of glucagon or adrenaline: it is appar- 
ently not mediated by cyclic AMP, since - in contrast 
with the two latter hormones - no increase in protein 
kinase activity is observed with vasopressin. A preli- 
minary communication describes part of these results 
PI. 
2. Materials and methods 
2.1, Experiments with intact rats 
The general procedure has been described 131. 
Briefly, pentobarbital anesthetized fed rats of 
about 300 g were used; liver biopsies were taken 
before and after the intravenous injection of the 
hormone and quick-frozen. 
2.2. Analytical methods 
For the assay of protein kinase (EC 2.7.1.37), a 
portion of a frozen liver sample was homogenized 
with 9 vol of a solution containing 250 mM sucrose, 
10 mM potassium-phosphate buffer pH 7.4,4 mM 
EDTA and 2 mM dithiotreitol. After a lo-fold 
dilution with the same solution, a 25 ~1 aliquot of 
the homogenate was incubated at 30°C in a final 
vol of 125 1.11, in the presence of 0.5 mM [y-3ZP]ATP 
and 5 mM magnesium acetate, with or without 
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1 Oe6 M cyclic AMP; two histone fractions were 
used at the following concentrations: histone II, 
(Sigma-type) at 0.6% and histone f& (nomenclature 
according to [4] ) at 0.05%. The rate of phosphory- 
lation was linear in time for about 6 min (see figs.2 
and 3). After 0,2,4, 6 and 8 min, a 20 pl-aliquot 
was spotted on filter paper and processed according 
to [S]. The activity is expressed as nmol phosphate 
incorporated per min and per g tissue. 
Glycogen phosphorylase a (EC 2.4.1.1.) and 
glycogen synthetase a (EC 2.4.1.11) were measured 
according to [3] except that the temperature was 
25°C instead of 20°C. 
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Fig. 1. The kinetics of the activation of liver glycogen phos- 
phorylase by vasopressin and by glucagon. Vasopressin (20 
mU) or glucagon (10 Irg) was injected intravenously to an 
anaesthetized rat. In each experiment, liver samples were 
taken at various time intervals from the same rat. 
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Fig. 2. Influence of a glucagon treatment on liver protein 
kinase. Two liver samples were taken from the same rat, 
one before and the other 1 min after the intravenous 
injection of glucagon (10 rg). Protein kinase was assayed 
with histone f2b as the substrate, either without or with 
10m6 M cyclic AMP. Phosphorylase activity was 7.8 U/g 
before and 17.5 U/g after glucagon. 
2.3. Chemicals 
[8-arginine]vasopressin (type VI) was obtained from 
Sigma Chemical Co. (St. Louis), glucagon from Novo- 
laboratories (Copenhagen) and adrenaline bitartrate 
from Federa (Brussels). Histones, ATP and cyclic AMP 
were from Sigma Chemical Co. 
3. Results 
Vasopressin (20 mU) caused a rapid activation of 
glycogen phosphorylase, clearly evident after 10 set 
and essentially complete within 30 set (frg.1). This 
rate of activation was at least as rapid as with 10 pg 
of glucagon (fig.1) and both hormones activated the 
enzyme to the same level (fig.1 and table 1) In these 
(fig. 1) and other experiments (not shown) glycogen 
synthetase remained at a low level of activity. 
The question arises whether vasopressin activates 
glycogen phosphorylase through an increased protein 
kinase activity, as it is generally accepted for glucagon 
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and adrenaline (see [6] ). Fig.2 shows a typical expe- 
riment illustrating the effect of glucagon on the 
activity of protein kinase: one min after the intra- 
venous injection of glucagon there was an almost 
trebling of the protein kinase activity assayed with- 
out added cyclic AMP (cyclic AMP independent 
protein kinase); no significant change in the total 
activity as measured with 10L6 M cyclic nucleotide 
was recorded. 
The effect of glucagon on glycogen phosphorylase 
and on protein kinase assayed with two different 
histone fractions is shown in table 1. On the average, 
glycogen phosphorylase was activated 2.6-fold; with 
histone fib as the substrate, cyclic AMP independent 
protein kinase activity was increased 2.7-fold and with 
histone II, 3.6.fold. Total protein kinase was not 
significantly influenced by the glucagon treament 
(table 1). Smaller amounts of glucagon, down to 
0.125 pg, were still clearly able to increase both the 
phosphorylase a level and the cyclic AMP independent 
protein kinase acting on histone f2b (not shown). 
Unlike glucagon, which can elevate the cyclic AMP 
level up to 60-fold, adrenaline raises this level at the 
most 2 to 4 times [7]. Therefore we have examined 
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Fig. 3. Influence of a vasopressin treatment on liver protein 
kinase. Same procedure as in fig.2. The rat received 20 mU 
of vasopressin. Phosphorylase activity was 8.4 U/g before 
and 16.4 U/g after treatment. 
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Table 1 
The effect of glucagon and vasopressin on liver glycogen phosphorylase 
and protein kinase 
Glucagon Vasopressin 
Enzyme CAMP Before After Before After 
Phosphorylase a 6.4 * 0.8 16.6* r 0.3 8.5 f 0.8 16.6* f 0.5 
(U/g liver) 
Protein kinase +f2b - 49 *4 130* + 7 49 53 47 * 2 
(mu/g liver) + 182 *4 185 + 10 238 f 3 233 f 6 
+ffA - 22 *5 81* f 10 32 +2 27 f 4 
+ 108 ?r. 5 98 f 3 105 f 9 120 r 11 
Two liver samples were taken from the same rat, one before and the other 1 min 
after the intravenous injection of glucagon (10 r.rg) or of vasopressin (20 mU). Pro- 
tein kinase was assayed with and without added cyclic AMP (10m6 M). Values shown 
are means r S.E.M. for 4-7 rats. Statistical significance was calculated from paired 
data. 
* KO.005 
whether such a moderate increase in the level of the 
cyclic nucleotide would be reflected in an enhanced 
protein kinase activity. One minute after the injection 
of 3 pg of adrenaline, the activation of glycogen 
phosphorylase was as complete as with glucagon and 
accompanied with a 1.6-fold increase in the cyclic 
AMP independent kinase activity assayed with histone 
f2b* 
The situation with vasopressin is quite different: 
indeed, the activation of phosphorylase is not associated 
with an increase in the cyclic AMP independent pro- 
tein kinase activity. Fig.3 illustrates how a one minute 
treatment with 20 mU of the hormone failed to enhance 
the cyclic AMP independent protein kinase activity as 
measured with histone fib. Neither were higher amounts 
of vasopressin (up to 85 mU) able to increase the 
hepatic protein kinase activity (not shown). 
Table 1 summarizes our data obtained with 20 mU 
of vasopressin: no increase of cyclic AMP independent 
protein kinase activity with neither histone fraction 
was apparent one minute after the application of the 
hormone, yet phosphorylase a had been doubled and 
brought to the same level as with glucagon. Total pro- 
tein kinase remained essentially constant. 
4. Discussion 
Our results show that the glycogenolytic effect of 
vasopressin is due to the activation of liver glycogen 
phosphorylase, the rate limiting enzyme in glycogen 
degradation. The activation of phosphorylase by vaso- 
pressin is at least as rapid as with glucagon and is as 
complete as with glucagon or adrenaline, the two 
well known glycogenolytic hormones. However, the 
mechanism involved appears different. 
Glucagon and adrenaline are known to act by their 
ability to stimulate the adenyl cyclase system: the 
increase in intracellular cyclic AMP activates the pro- 
tein kinase and this will ultimately lead to the con- 
version of glycogen phosphorylase b to a [6]. We have 
found indeed that both glucagon and adrenaline acti- 
vate liver protein kinase. The rise in kinase activity is 
more marked with glucagon than with adrenaline; 
this is in agreement with the different increases in 
cyclic AMP concentrations known to be produced by 
these hormones, glucagon being much more efficient 
than adrenaline [7]. The degree of kinase activation 
with glucagon is similar to that reported recently by 
Sudilovsky [ 81. 
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Vasopressin however does not enhance the cyclic 
AMP independent protein kinase activity in the liver. 
Yet, our assay is sensitive enough to detect a 2 to 4- 
fold increase in the level of cyclic AMP, the maximal 
raise which can be obtained with adrenaline [7]. The 
lack of effect of vasopressin on protein kinase suggests 
therefore that it may activate liver glycogen phospho- 
rylase by a mechanism different from that of glucagon 
and adrenaline, i.e. not mediated by cyclic AMP. This 
conclusion is supported by the corroborative data of 
Kirk and Hems [9] who reported very recently that 
vasopressin (up to 100 mU per rat) fails to raise the 
cyclic AMP level in rat liver. 
In summary, the glycogenolytic action of vaso- 
pressin in the liver is explained by a prompt activa- 
tion of glycogen phosphorylase; this activation, 
apparently not mediated by cyclic AMP nor by an 
increased protein kinase activity, seems to be due 
to a novel mechanism. 
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